What type of study is this?

This is a Case-Control Study study.

Endocrine complications in patients with β-thalassemia major receiving iron-chelation therapy

View Full Paper

Ask AI

Bookmark

Authors

Case-control study shows endocrine dysfunction in β-thalassemia major patients, suggesting need for routine assessment.

The study aims to assess the prevalence of endocrine dysfunction in β-thalassemia major patients undergoing iron-chelation therapy.
Case-control study with 60 β-thalassemia major patients and 20 controls
Measurement of hormonal and biochemical parameters
Correlation analysis between iron status and endocrine function
73.3% of patients were splenectomized
15% had subclinical primary hypothyroidism
51.7% had HbA1c ≥6.5% indicating impaired glucose metabolism
71.7% were vitamin D deficient despite receiving supplements
Ferritin was positively correlated with FGF21 levels

Al-Sanabra et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Case-control study shows endocrine dysfunction in β-thalassemia major patients, suggesting need for routine assessment.

The study aims to assess the prevalence of endocrine dysfunction in β-thalassemia major patients undergoing iron-chelation therapy.
Case-control study with 60 β-thalassemia major patients and 20 controls
Measurement of hormonal and biochemical parameters
Correlation analysis between iron status and endocrine function
73.3% of patients were splenectomized
15% had subclinical primary hypothyroidism
51.7% had HbA1c ≥6.5% indicating impaired glucose metabolism
71.7% were vitamin D deficient despite receiving supplements
Ferritin was positively correlated with FGF21 levels

Al-Sanabra et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark